|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Other receivable | |||||||||||||
| Income tax receivable | |||||||||||||
| Total Current Assets | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities, Redeemable Common Stock, and Stockholders’ Deficit | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Accrued expenses – related party | |||||||||||||
| Accrued offering costs paid by related party | |||||||||||||
| Franchise tax accrual | |||||||||||||
| Due to DRIVEiT (target company) | |||||||||||||
| Franchise tax payable | |||||||||||||
| Income tax payable | |||||||||||||
| Excise tax payable | |||||||||||||
| Deferred credit - term extension fee funded by acquisition target company | |||||||||||||
| Promissory notes - related party | |||||||||||||
| Redeemed common stock payable to public stockholders | |||||||||||||
| Promissory note - DRIVEiT (target company) | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Deferred underwriting fee payable | |||||||||||||
| Total Liabilities | |||||||||||||
| Common stock subject to possible redemption, 464,105 shares at redemption value of $12.03 and $11.67 per share as of March 31, 2025 and December 31, 2024, respectively | |||||||||||||
| Stockholders’ Deficit | |||||||||||||
| Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,218,499 shares issued and outstanding (excluding 464,105 shares subject to possible redemption) | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Stockholders’ Deficit | |||||||||||||
| Total Liabilities, Redeemable Common Stock, and Stockholders’ Deficit | |||||||||||||
Loading...
